Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lucid Diagnostics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −4 vs. Q4 2022
- Shares held
- 1.77M
- −147.4K (−7.7%) vs. Q4 2022
- Total value
- $2.49M
- −$117.9K (−4.5%) vs. Q4 2022
- New holders
- 1
- 6 more added
- Sold out
- 5
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.0M |
| Q3 2025 | 86 | $35.5M |
| Q2 2025 | 72 | $21.7M |
| Q1 2025 | 49 | $14.0M |
| Q4 2024 | 33 | $2.70M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.64M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.46M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.52M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 59 | $83 | 0.00% | +1+1.7% | Added |
| Morgan Stanley | 800 | $1.12K | 0.00% | −93−10.4% | Reduced |
| Belpointe Asset Management LLC | 1,500 | $2.10K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,000 | $2.80K | 0.00% | +1,000+100.0% | Added |
| CWM, LLC | 1,920 | $3.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,558 | $3.58K | 0.00% | −1,007−28.2% | Reduced |
| Tower Research Capital LLC (TRC) | 3,093 | $4.00K | 0.00% | +532+20.8% | Added |
| State Street Corp | 10,521 | $14.7K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 14,400 | $20.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,545 | $22.0K | 0.00% | +15,545 | New |
| BlackRock Inc. | 18,856 | $26.4K | 0.00% | +618+3.4% | Added |
| Geneos Wealth Management Inc. | 33,850 | $47.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 41,543 | $58.2K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 50,462 | $70.6K | 0.00% | +14,296+39.5% | Added |
| Bridgeway Capital Management, LLC | 135,000 | $189.0K | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 261,664 | $376.8K | 0.04% | −17,873−6.4% | Reduced |
| Vanguard Group Inc | 319,433 | $447.2K | 0.00% | 00.0% | Unchanged |
| Luminus Management LLC | 855,300 | $1.20M | 0.29% | +30,300+3.7% | Added |
| Kornitzer Capital Management Inc | 0 | $0 | 0.00% | −133,000−100.0% | Sold out |
| Levin Capital Strategies, L.P. | 0 | $0 | 0.00% | −36,799−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,814−100.0% | Sold out |
| Arcus Capital Partners, LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −18−100.0% | Sold out |